Clinical management of thrombosis in inherited factor III deficiency: A description of two cases

Thrombosis and Haemostasis

Volumn 101, Issue 2, 2009, Pages 402-404

  Arellano Rodrigo, Eduardo ^a   Gironella, Mercedes ^a   Nicolau, Inmaculada ^a   Vila, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN; VITAMIN K GROUP; ANTICOAGULANT AGENT;

AGED; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BRAIN INFARCTION; BRUISING; CASE REPORT; CLINICAL ASSESSMENT; DEEP VEIN THROMBOSIS; DRUG WITHDRAWAL; EPISTAXIS; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA; THROMBOSIS; THROMBOSIS PREVENTION; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG MONITORING; TIME; TREATMENT OUTCOME;

ACENOCOUMAROL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DRUG MONITORING; ENOXAPARIN; FACTOR VII DEFICIENCY; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; RISK ASSESSMENT; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 62449214897     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-09-0572     Document Type: Article

References (17)

1. Acharya SS, Coughlin A, Dimichele DM; the North American Rare Bleeding Disorders Study Group, Rare Bleeding Disorder Registry: deficiencies of factors II, V. VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2: 248-256.
2. Cooper DN, Millar DS, Wacey A, et al. Inherited factor VII deficiency: molecular genetics and pathophysiology. Thromb Haemost 1997; 78: 151-160.
3. Mariani G, Herrmann FH, Dolce A, et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 2005; 93: 481-487.
4. Giansily-Blaizot M, Schved JE Potential predictors of bleeding risk in inherited factor VII deficiency: Clinical, biological and molecular criteria. Thromb Haemost 2005; 94: 901-906.
5. Mariani G, Herrmann FH, Schulman S, et al. Thrombosis in inherited factor VII deficiency. J Thromb Haemost 2004; 1: 2153-2158.
6. Girolami A, Ruzzon E, Tezza F, et al. Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review. Haemophilia 2006: 12: 345-351.
7. Marty S, Barro C, Chatelain B, et al. The paradoxical association between inherited factor VII deficiency and venous thrombosis. Haemophilia 2008; 14: 564-570.
8. Barcellona D, Vannini ML, Fenu L, et al. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants? Thromb Haemost 1998; 80: 899-902.
9. D' Angelo A, Delia VP, Crippa L, et al. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment. Haematologica 2002; 87: 1074-1080.
10. Watala C, Golanski J, Kardas P. Multivariate relationships between international normalized ratio and vitamin K-dependent coagulation-derived parameters in normal healthy donors and oral anticoagulant therapy patients. Thromb J 2003; 1: e7.
11. Giansily-Blaizot M, Verdier R, Biron-Adreani C, et al., Study group of FVII deficiency. Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk? Haematologica 2004 89: 704-709.
12. Baltodano LE, Mungall DR, Watson DD. Management of a patient with atrial fibrillation and factor VII deficiency. Ann Pharmacother 1998; 32: 1251-1252.
13. Younger JR, McHenry JG. Visually disabling nontraumatic orbital hemorrhage in an anticoagulated patient with factor VII deficiency. J Neuro-Ophthalmol 2006;26:76-77.
14. Barnett JM. Demel KC, Mega AE, et al. Lack of bleeding in patients with severe factor VII deficiency. Am J Hematol 2005; 78: 134-137.
15. Bolt G, Steenstrup TD, Kristensen C. All post-translational modifications except propeptide cleavage are required for optimal secretion of coagulation factor VII. Thromb Haemost 2007; 98: 988-997.
16. Presnell SR, Stafford DW. The vitamin K-dependent carboxylase. Thromb Haemost 2002; 87: 937-946.
17. Gray E, Mulloy B, Barroweliffe TW. Heparin and low-molecular-weight heparin. Thromb Haemost 2008; 99: 807-818.